9-130755834-T-C

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The ENST00000372348.9(ABL1):​c.136+41379T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.534 in 152,072 control chromosomes in the GnomAD database, including 23,595 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.53 ( 23595 hom., cov: 32)

Consequence

ABL1
ENST00000372348.9 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.905

Publications

6 publications found
Variant links:
Genes affected
ABL1 (HGNC:76): (ABL proto-oncogene 1, non-receptor tyrosine kinase) This gene is a protooncogene that encodes a protein tyrosine kinase involved in a variety of cellular processes, including cell division, adhesion, differentiation, and response to stress. The activity of the protein is negatively regulated by its SH3 domain, whereby deletion of the region encoding this domain results in an oncogene. The ubiquitously expressed protein has DNA-binding activity that is regulated by CDC2-mediated phosphorylation, suggesting a cell cycle function. This gene has been found fused to a variety of translocation partner genes in various leukemias, most notably the t(9;22) translocation that results in a fusion with the 5' end of the breakpoint cluster region gene (BCR; MIM:151410). Alternative splicing of this gene results in two transcript variants, which contain alternative first exons that are spliced to the remaining common exons. [provided by RefSeq, Aug 2014]
ABL1 Gene-Disease associations (from GenCC):
  • congenital heart defects and skeletal malformations syndrome
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae), PanelApp Australia, G2P
  • connective tissue disorder
    Inheritance: AD Classification: MODERATE Submitted by: Genomics England PanelApp
  • bone development disease
    Inheritance: AR Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.9).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.76 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: ENST00000372348.9. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ABL1
NM_007313.3
c.136+41379T>C
intron
N/ANP_009297.2

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ABL1
ENST00000372348.9
TSL:1
c.136+41379T>C
intron
N/AENSP00000361423.2
ABL1
ENST00000393293.4
TSL:5
c.136+41379T>C
intron
N/AENSP00000376971.4

Frequencies

GnomAD3 genomes
AF:
0.533
AC:
81048
AN:
151954
Hom.:
23547
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.767
Gnomad AMI
AF:
0.356
Gnomad AMR
AF:
0.558
Gnomad ASJ
AF:
0.508
Gnomad EAS
AF:
0.631
Gnomad SAS
AF:
0.556
Gnomad FIN
AF:
0.368
Gnomad MID
AF:
0.595
Gnomad NFE
AF:
0.405
Gnomad OTH
AF:
0.552
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.534
AC:
81156
AN:
152072
Hom.:
23595
Cov.:
32
AF XY:
0.534
AC XY:
39730
AN XY:
74336
show subpopulations
African (AFR)
AF:
0.767
AC:
31818
AN:
41472
American (AMR)
AF:
0.557
AC:
8505
AN:
15260
Ashkenazi Jewish (ASJ)
AF:
0.508
AC:
1765
AN:
3472
East Asian (EAS)
AF:
0.631
AC:
3258
AN:
5166
South Asian (SAS)
AF:
0.556
AC:
2679
AN:
4822
European-Finnish (FIN)
AF:
0.368
AC:
3897
AN:
10576
Middle Eastern (MID)
AF:
0.599
AC:
176
AN:
294
European-Non Finnish (NFE)
AF:
0.405
AC:
27559
AN:
67988
Other (OTH)
AF:
0.556
AC:
1174
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
1783
3566
5350
7133
8916
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
674
1348
2022
2696
3370
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.448
Hom.:
7748
Bravo
AF:
0.562
Asia WGS
AF:
0.584
AC:
2031
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.90
CADD
Benign
13
DANN
Benign
0.35
PhyloP100
0.91
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2583836; hg19: chr9-133631221; API